DEVELOPMENT AGREEMENTDevelopment Agreement • April 19th, 2023 • Delaware
Contract Type FiledApril 19th, 2023 JurisdictionThis Development Agreement (this “Agreement”) is made and entered into on June 4, 2015 (the “Effective Date”) by and between Tandem Diabetes Care, Inc., a Delaware corporation, having a principal place of business at 11045 Roselle St., San Diego, CA 92121 (“Tandem”) and DexCom, Inc., a Delaware corporation, having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (“DexCom”).
DEVELOPMENT AGREEMENTDevelopment Agreement • April 19th, 2023 • Delaware
Contract Type FiledApril 19th, 2023 JurisdictionThis Development Agreement (this “Agreement”) is made and entered into on June 4, 2015 (the “Effective Date”) by and between Tandem Diabetes Care, Inc., a Delaware corporation, having a principal place of business at 11045 Roselle St., San Diego, CA 92121 (“Tandem”) and DexCom, Inc., a Delaware corporation, having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (“DexCom”).
DEVELOPMENT AGREEMENTDevelopment Agreement • November 9th, 2018 • Tandem Diabetes Care Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledNovember 9th, 2018 Company Industry JurisdictionThis Development Agreement (this “Agreement”) is made and entered into on June 4, 2015 (the “Effective Date”) by and between Tandem Diabetes Care, Inc., a Delaware corporation, having a principal place of business at 11045 Roselle St., San Diego, CA 92121 (“Tandem”) and DexCom, Inc., a Delaware corporation, having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (“DexCom”).
DEVELOPMENT AGREEMENTDevelopment Agreement • November 1st, 2018 • Tandem Diabetes Care Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledNovember 1st, 2018 Company Industry JurisdictionThis Development Agreement (this “Agreement”) is made and entered into on June 4, 2015 (the “Effective Date”) by and between Tandem Diabetes Care, Inc., a Delaware corporation, having a principal place of business at 11045 Roselle St., San Diego, CA 92121 (“Tandem”) and DexCom, Inc., a Delaware corporation, having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (“DexCom”).
DEVELOPMENT AGREEMENTDevelopment Agreement • October 26th, 2017 • Tandem Diabetes Care Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledOctober 26th, 2017 Company Industry JurisdictionThis Development Agreement (this “Agreement”) is made and entered into on June 4, 2015 (the “Effective Date”) by and between Tandem Diabetes Care, Inc., a Delaware corporation, having a principal place of business at 11045 Roselle St., San Diego, CA 92121 (“Tandem”) and DexCom, Inc., a Delaware corporation, having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (“DexCom”).